| 4 268. The demon stration of clinical or subclinical LEAD is essential if gangrene is to be considered a manifestation of the progression of LEAD in the individual patient. Changing incidence and survival in patients with AIDSrelated nonHodgkins lymphomas in the era of HAART. 1 p. New and old. |